Psyched Wellness Ltd. (PSYCF) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Psyched Wellness Ltd. (PSYCF) Consumer Business Overview

Psyched Wellness Ltd. is a health supplements company specializing in artisanal, medicinal mushroom products, notably Amanita Muscaria Tincture, targeting the consumer packaged goods market within the Consumer Defensive sector. The company aims to provide natural solutions for stress relief and improved sleep, differentiating itself through unique mushroom-based formulations.

What Is the Investment Thesis for PSYCF?

Psyched Wellness Ltd. presents a speculative investment opportunity within the emerging market for medicinal mushroom-based health supplements. The company's focus on Amanita Muscaria Tincture, positioned as a natural stress-relief and sleep aid, aligns with growing consumer interest in alternative wellness solutions. However, the company's negative profit margin of -1230.8% and gross margin of -46.3% indicate significant challenges in achieving profitability. Growth catalysts include potential regulatory approvals for its products and expansion into new markets. Key risks include competition from established players in the health supplements industry and uncertainties surrounding the regulatory landscape for Amanita Muscaria. Investors should carefully consider the company's financial performance, market position, and regulatory risks before making investment decisions. The company's beta of 0.96 suggests a market risk level close to the overall market.

Based on FMP financials and quantitative analysis

PSYCF Key Highlights

Market capitalization of $1.57M indicates a micro-cap company with limited financial resources.

• Negative P/E ratio of -0.98 reflects current losses and the absence of positive earnings.
• Profit margin of -1230.8% highlights significant operational inefficiencies and challenges in achieving profitability.
• Gross margin of -46.3% indicates that the cost of goods sold exceeds revenue, posing a major concern for the company's financial sustainability.
• Beta of 0.96 suggests the stock's price is slightly less volatile than the overall market.

Who Are PSYCF's Competitors?

PSYCF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are PSYCF's Key Strengths?

Unique product offering based on medicinal mushrooms.

• Focus on the growing market for natural health supplements.
• Potential for intellectual property protection.
• Experienced management team in the health and wellness industry.

What Are PSYCF's Weaknesses?

Limited financial resources and market capitalization.

• Negative profit margins and gross margins.
• Dependence on a single product (Amanita Muscaria Tincture).
• Lack of established brand recognition.

What Could Drive PSYCF Stock Higher?

Potential regulatory approvals for Amanita Muscaria Tincture in key markets.

• Expansion of distribution network through partnerships with retailers and online marketplaces.
• Product line diversification with new mushroom-based formulations.
• Positive research findings validating the efficacy of its products.
• Increasing consumer awareness of the benefits of medicinal mushrooms.

What Are the Key Risks for PSYCF?

Financial-distress signal — its Altman Z-Score of -28.38 sits in the distress zone (elevated bankruptcy risk).

• Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
• Competition from established players in the health supplements industry.
• Regulatory uncertainties surrounding Amanita Muscaria.
• Negative publicity or safety concerns related to mushroom-based products.
• Economic downturn affecting consumer spending on discretionary health products.
• Limited financial resources and market capitalization.

What Are the Growth Opportunities for PSYCF?

• Expansion into new markets: Psyched Wellness can pursue growth by expanding its distribution network to reach new geographic markets. This could involve partnerships with retailers, online marketplaces, and distributors in regions where there is growing demand for natural health supplements. The global health and wellness market is estimated to be worth trillions of dollars, providing ample opportunity for expansion. Timeline: Ongoing.
• Product line diversification: The company can diversify its product line by developing new formulations and delivery methods for its mushroom-based ingredients. This could include capsules, powders, teas, and other consumer-friendly formats. Expanding the product line can attract a wider range of customers and increase revenue streams. The market for functional foods and beverages is experiencing rapid growth, driven by consumer interest in health and wellness. Timeline: Ongoing.
• Strategic partnerships: Psyched Wellness can form strategic partnerships with complementary businesses, such as wellness centers, health food stores, and online retailers. These partnerships can provide access to new customers, distribution channels, and marketing resources. Collaborations with research institutions can also help to validate the efficacy of its products and enhance its credibility. Timeline: Ongoing.
• E-commerce and direct-to-consumer sales: The company can invest in its e-commerce platform and direct-to-consumer sales channels to reach customers directly and build brand loyalty. This can involve targeted online advertising, social media marketing, and email campaigns. The e-commerce market for health and wellness products is growing rapidly, providing a significant opportunity for Psyched Wellness. Timeline: Ongoing.
• Research and development: Continued investment in research and development is crucial for validating the efficacy and safety of Psyched Wellness' products. This can involve clinical trials, scientific studies, and collaborations with research institutions. Positive research findings can enhance the company's credibility, attract new customers, and support regulatory approvals. Timeline: Ongoing.

What Are PSYCF's Competitive Advantages?

• Proprietary formulations of mushroom-based supplements.
• Brand recognition in the niche market of medicinal mushroom products.
• Potential intellectual property protection for its unique products and processes.
• First-mover advantage in the emerging market for Amanita Muscaria-based supplements.

What Does PSYCF Do?

Psyched Wellness Ltd., formerly known as Duncan Park Holdings Corporation, was incorporated in 2019 and rebranded in July 2020 to focus on the burgeoning market for health supplements derived from medicinal mushrooms. Based in Toronto, Canada, the company is engaged in the production and distribution of artisanal consumer packaged goods centered around these unique ingredients. Their flagship product, Amanita Muscaria Tincture, is marketed for its potential to soothe the body, alleviate physical distress, reduce stress, ease muscular tension, and promote restorative sleep. The company's strategic focus is on developing and commercializing products that leverage the purported health benefits of Amanita Muscaria and other medicinal mushrooms. Psyched Wellness aims to establish itself as a leading provider of natural health solutions within the consumer packaged goods segment. The company's operations encompass sourcing, processing, and packaging of mushroom-based ingredients, as well as marketing and distribution to reach its target consumer base. As a relatively young company, Psyched Wellness is in the early stages of building its brand and establishing its market presence in the competitive health supplements industry. The company manages 1800 employees.

What Products and Services Does PSYCF Offer?

• Produces artisanal, medicinal mushroom products.
• Focuses on health supplements.
• Offers Amanita Muscaria Tincture.
• Aims to provide natural solutions for stress relief.
• Markets products to promote restorative sleep.
• Engages in the distribution of consumer packaged goods.

How Does PSYCF Make Money?

• Develops and manufactures health supplements based on medicinal mushrooms.
• Markets and distributes products through various channels, potentially including online sales and retail partnerships.
• Generates revenue through the sale of its Amanita Muscaria Tincture and other mushroom-based products.

What Industry Does PSYCF Operate In?

Psyched Wellness Ltd. operates within the Consumer Defensive sector, specifically in the Packaged Foods industry. This sector is generally considered stable, as demand for food and health-related products tends to remain consistent regardless of economic conditions. However, the market for medicinal mushroom-based supplements is relatively new and rapidly evolving. The company faces competition from established players in the broader health supplements industry, as well as emerging companies focused on similar niche markets. The industry is subject to regulatory scrutiny, particularly regarding the safety and efficacy of novel ingredients like Amanita Muscaria.

Who Are PSYCF's Key Customers?

• Individuals seeking natural stress relief and relaxation aids.
• Consumers interested in alternative health and wellness solutions.
• Customers looking for products to promote restorative sleep.
• Health-conscious individuals seeking natural supplements.

Psyched Wellness Ltd.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -28.38 places it in the distress zone, a signal of elevated financial risk.

Quarterly Financial Performance: Psyched Wellness Ltd.

Revenue for Psyched Wellness Ltd. came in at $178K during Q2 2026, a 24.9% contraction versus the preceding quarter. The company recorded a net loss of $1.6M, with diluted EPS of $-0.00. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Consumer Defensive. Across the four most recent quarters, PSYCF averaged $-0.00 in diluted EPS.

PSYCF Valuation & Market Position

With a $1.57M market cap, Psyched Wellness Ltd. sits in the micro-cap segment of the market. Relative to its peer group, PSYCF's quantitative score of 55/100 is roughly in line with the peer average of 56/100.

Company Profile

Psyched Wellness Ltd. operates in the Household & Personal Products industry within the Consumer Defensive sector. It is headquartered in Toronto, CA. The company is led by CEO Michael Nederhoff. PSYCF has traded publicly since 2021.

PSYCF Financials

PSYCF Latest News

No recent news available for PSYCF.

PSYCF Analyst Consensus

PSYCF MoonshotScore

Psyched Wellness Ltd. Consumer Defensive Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources